EuropaBio input to the Public Consultation in Preparation of a Legal Proposal to Combat Counterfeit Medicines for Human Use 

14.05.2008

EuropaBio input to the Public Consultation in Preparation of a Legal Proposal to Combat Counterfeit Medicines for Human Use 

Re: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE

To whom it may concern

Thank you very much for the opportunity to input into the above consultation.

EuropaBio is the European Association for Bioindustries, solely and uniquely bringing together bioscience companies from all fields of research and development, testing, manufacturing and distribution of biotechnology products. It has 84 corporate members operating worldwide, 8 associate members, 6 BioRegions and 25 national biotechnology associations representing some 1800 small and medium sized enterprises involved in research. Its mission is to promote an innovative and dynamic biotechnology-based industry in Europe.

Healthcare biotechnology, in particular, is already having a tremendous impact on our lives, and biotech therapies will continue to represent the state-of-the-art evolution of science as applied to human medicine. They present novel approaches to patient disease management, and the technology itself is providing us with a better understanding on the course and mechanisms of disease. Innovative European biotechnology companies are now defining diseases at a molecular level, distinguishing between different disease states, and connecting genomics-identified targets with particular disease pathologies.

Latest Position papers